At 5.5% CAGR, Middle East & Africa Non-Invasive Ventilation Masks Market is Projected to be worth US$ 92.61 million by 2031, says Business Market Insights

According to Business Market Insights’ research, the Middle East & Africa non-invasive ventilation masks market was valued at US$ 60.54 million in 2023 and is expected to reach US$ 92.61 million by 2031, registering a CAGR of 5.5% from 2023 to 2031. Increasing prevalence of respiratory diseases and growing inclination towards home healthcare are among the critical factors attributed to drive the Middle East & Africa non-invasive ventilation masks market growth.

The prevalence of respiratory illnesses such as asthma, obstructive sleep apnea (OSA), and chronic obstructive pulmonary disease (COPD) is rising worldwide. Invasive ventilation methods are often avoided in COPD patients to reduce risks of complications such as infections and mechanical lung injuries. Noninvasive ventilation (NIV) masks are preferred because they provide breathing support without requiring intubation. Thus, the chronic, long-term nature of COPD and sleep apnea leads to repeat purchases and creates a demand for NIV masks, thereby generating a steady, sustainable market for manufacturers.

On the contrary, side effects associated with NIV masks hamper the growth of Middle East & Africa non-invasive ventilation masks market.

By product, the Middle East & Africa non-invasive ventilation masks market is bifurcated into noninvasive ventilation disposable mask and noninvasive ventilation reusable mask. The noninvasive ventilation disposable mask segment held 61.3% share of Middle East & Africa non-invasive ventilation masks market share in 2023, amassing US$ 37.13 million. It is projected to garner US$ 55.65 million by 2031 to register 5.2% CAGR during 2023–2031.

In terms of application, the Middle East & Africa non-invasive ventilation masks market is segmented into sleep apnea, chronic obstructive pulmonary disease, pneumonia, and others. The sleep apnea segment held 56.9% share of Middle East & Africa non-invasive ventilation masks market share in 2023, amassing US$ 34.47 million. It is projected to garner US$ 53.66 million by 2031 to register 5.7% CAGR during 2023–2031.

Based on end user, the Middle East & Africa non-invasive ventilation masks market is segmented into hospitals and clinics, home care, and others. The hospitals and clinics segment held 50.7% share of Middle East & Africa non-invasive ventilation masks market share in 2023, amassing US$ 220.08 million. It is projected to garner US$ 372.26 million by 2031 to register 6.8% CAGR during 2023–2031.

Based on country, the Middle East & Africa non-invasive ventilation masks market is categorized into South Africa, Saudi Arabia, the U.A.E, and the Rest of Middle East & Africa. Our regional analysis states that Saudi Arabia captured 34.7% share of Middle East & Africa non-invasive ventilation masks market in 2023. It was assessed at US$ 21.00 million in 2023 and is likely to hit US$ 32.51 million by 2031, registering a CAGR of 5.6% during 2023–2031.

Key players operating in the non-invasive ventilation masks market are Air Liquide Medical Systems; Armstrong Medical Ltd; Besmed Health Business Corp; BMC Medical Co Ltd; DeVilbiss Healthcare LLC; Dimar S.P.A.; Dragerwerk AG & Co KGaA; Fisher & Paykel Healthcare Corp Ltd; Hamilton Medical AG; Hangzhou Formed Medical Devices Co., Ltd; Intersurgical Ltd; Koninklijke Philips NV; Medline Industries LP; ResMed Inc; Sleepnet Corporation; SunMed Group Holdings LLC ( AirLife); and SURU INTERNATIONAL PVT. LTD.; among others.

• In May 2022: Air Liquide Healthcare launched ALNEST N1 Silent mask. Alnest N1 Silent and Alnest N1 are reusable nasal masks with calibrated exhalation orifices (vented) for adult patients (weighing more than 30 kg) undergoing non-invasive positive pressure ventilation therapy (NPPV) like CPAP or BiPAP.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com